Aleyna Yildiz is addressing the limited treatment options and poor prognosis of Diffuse Intrinsic Pontine Glioma (DIPG), a common childhood brain tumour. Her proposed solution involves gene therapy to imitate mutations of the H3K27M gene, aiming to prolong life expectancy and control symptoms, with the potential vaccine classified as an orphan drug designed for treating rare diseases.
Falling Walls
Falling Walls Science Summit 2023
Login or Register
You need to be logged in to use this feature.
Breaking the Wall of Childhood Brain Cancer
Aleyna Yıldız is the Co-Founder of AGON Biotechnology. AGON Biotechnology, which carries out research and development projects on biosensors and medical devices, has develops and produces electronic components as well as bacterial sensors.
Further Activities to have a look at